Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Validation of a Dutch version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: an observational web-based study.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Dimethyl fumarate for treatment of multiple sclerosis: mechanism of action, effectiveness, and side effects.
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
A case of demyelinating polyneuropathy associated with anti-myelin-associated glycoprotein antibodies with progressive quadriparesis and respiratory failure.
Social support and depressive symptoms among caregivers of veterans with multiple sclerosis.
Clinical Neurophysiology in multiple sclerosis - From diagnostic tool to biomarker.
A Low-Cost Cognitive Rehabilitation With a Commercial Video Game Improves Sustained Attention and Executive Functions in Multiple Sclerosis: A Pilot Study.
Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases.
Tau protein levels in the cerebrospinal fluid of the patients with multiple sclerosis in an attack period: Low levels of tau protein may have significance, too.
Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
Therapeutic options in neuromyelitis optica spectrum disorders.
FDG PET/CT in Acute Tumefactive Multiple Sclerosis Occurring in a Case of Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
Aerobic and resistance exercise improve walking speed and endurance in people with multiple sclerosis [synopsis].
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial.
Longitudinal PET imaging for monitoring myelin repair in the spinal cord.
Low myo-inositol indicating astrocytic damage in a case series of NMO.
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
[Contribution of cerebral magnetic resonance imaging to etiological investigation of uveitis.]
Measuring Gray Matter and White Matter Damage in MS: Why This is Not Enough.

Pages